TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.

David R Spigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.